Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Del Bo

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Neurology|March 15, 2006
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutationR Del Bo, F Locatelli, S Corti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2008
DPP6 gene variability confers increased risk of developing sporadic amyotrophic lateral sclerosis in Italian patientsR Del Bo, S Ghezzi, S Corti, et al.
Journal of Hematotherapy & Stem Cell Research|February 24, 2004
Neuronal differentiation of murine bone marrow Thy-1- and Sca-1-positive cellsF Locatelli, S Corti, C Donadoni, et al.
Neuro-Degenerative Diseases|February 12, 2011
Genetic background predicts poor prognosis in frontotemporal lobar degenerationB Borroni, M Grassi, S Archetti, et al.
Cellular and Molecular Life Sciences : CMLS|March 7, 2001
T-antigen regulated expression reduces apoptosis of tag-transformed human myoblastsS Corti, S Salani, R Del Bo, et al.
Human Molecular Genetics|August 1, 2000
Transplacental injection of somite-derived cells in mdx mouse embryos for the correction of dystrophin deficiencyY Torrente, M G D'Angelo, Z Li, et al.
Rejuvenation Research|August 30, 2008
Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degenerationB Borroni, S Ghezzi, C Agosti, et al.
Muscle & Nerve|July 1, 1996
In vivo biolistic technique in control and mdx dystrophic miceC D Ausenda, N Bresolin, A De Liso, et al.
Cell Transplantation|August 12, 1999
Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx miceY Torrente, M G D'Angelo, R Del Bo, et al.
Cell Transplantation|May 3, 2001
In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantationR Del Bo, Y Torrente, S Corti, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Neurology|March 15, 2006
Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutationR Del Bo, F Locatelli, S Corti, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 19, 2008
DPP6 gene variability confers increased risk of developing sporadic amyotrophic lateral sclerosis in Italian patientsR Del Bo, S Ghezzi, S Corti, et al.
Journal of Hematotherapy & Stem Cell Research|February 24, 2004
Neuronal differentiation of murine bone marrow Thy-1- and Sca-1-positive cellsF Locatelli, S Corti, C Donadoni, et al.
Neuro-Degenerative Diseases|February 12, 2011
Genetic background predicts poor prognosis in frontotemporal lobar degenerationB Borroni, M Grassi, S Archetti, et al.
Cellular and Molecular Life Sciences : CMLS|March 7, 2001
T-antigen regulated expression reduces apoptosis of tag-transformed human myoblastsS Corti, S Salani, R Del Bo, et al.
Human Molecular Genetics|August 1, 2000
Transplacental injection of somite-derived cells in mdx mouse embryos for the correction of dystrophin deficiencyY Torrente, M G D'Angelo, Z Li, et al.
Rejuvenation Research|August 30, 2008
Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degenerationB Borroni, S Ghezzi, C Agosti, et al.
Muscle & Nerve|July 1, 1996
In vivo biolistic technique in control and mdx dystrophic miceC D Ausenda, N Bresolin, A De Liso, et al.
Cell Transplantation|August 12, 1999
Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx miceY Torrente, M G D'Angelo, R Del Bo, et al.
Cell Transplantation|May 3, 2001
In vitro and in vivo tetracycline-controlled myogenic conversion of NIH-3T3 cells: evidence of programmed cell death after muscle cell transplantationR Del Bo, Y Torrente, S Corti, et al.
Pageof 4